We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Rules Glenmark Infringed Bayer’s Finacea Patent

Law360, New York (May 16, 2016, 4:07 PM EDT) -- The Federal Circuit on Monday affirmed a lower court’s ruling that Glenmark infringed a Bayer Healthcare patent for the rosacea treatment Finacea, keeping Glenmark's planned generic version off the market until the...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

August 5, 2015

Law Firms


Government Agencies


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.